Strata Critical Medical, Inc.
SRTA- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001779128
In the last 90 days, Strata Critical Medical, Inc. insiders filed 0 open-market purchases and 1 sale; 139 institutions reported holding it in 13F filings for Q2 2026, worth $281.4M in total; superinvestors Third Point and ARK Invest hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Strata Critical Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $29.3K in total
- Insiders trading
- 1
- Net value
- −$29.3K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Strata Critical Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tomkiel Melissa M. | Co-CEO and General Counsel | 2,153,678 | Sep 25, 2026 | 12 |
| Heyburn William A. | Co-CEO and CFO | 1,757,850 | Sep 25, 2026 | 9 |
| Verdetto Louis R. | CEO, Clinical Services | 1,128,096 | Sep 10, 2026 | 2 |
| Wunsch Scott M | CEO, Logistics | 663,043 | Sep 10, 2026 | 9 |
| Cohen Amir | Chief Accounting Officer | 177,154 | Sep 10, 2026 | 11 |
| Love Reginald | Director | 146,481 | Aug 13, 2026 | 4 |
| Cook William L. III | Director | 97,671 | Aug 3, 2026 | 2 |
| Philip Edward M | Director | 265,078 | Aug 3, 2026 | 1 |
| Wiesenthal Robert S | Director | 5,325,896 | Aug 3, 2026 | 1 |
| Lauck Andrew | Director | 170,902 | Aug 3, 2026 | 2 |
| Krstic Velibor | 10% Owner | – | May 8, 2026 | 1 |
| Lerer Kenneth B | Director | 165,964 | Aug 5, 2025 | 0 |
| Lyne Susan M | Director | 187,185 | Aug 5, 2025 | 0 |
| Affeldt Eric | Director | 165,964 | Aug 5, 2025 | 0 |
| Borthwick John | Director | 203,977 | Aug 5, 2025 | 0 |
| Bacon Seth J | CEO, Trinity Air Medical | 340,785 | Jun 17, 2024 | 0 |
| Garvey Jane C | Director | 123,264 | Aug 9, 2023 | 0 |
| Keene Brandon A. | Chief Innovation Officer | 318,589 | Nov 21, 2022 | 0 |
| Arkhipenko Anatoli | Chief Technology Officer | 111,754 | Nov 14, 2022 | 0 |
| Resnick Eric Charles | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Experience Sponsor LLC | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Steele ExpCo Holdings, LLC | 10% Owner | 0 | Jan 24, 2022 | 0 |
| Zaslav David | Director | 45,022 | Sep 24, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −11.0K | $3.05 | −$33.6K | −11.5%84.4K after | |
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Love ReginaldDirector | PPurchaseClass A common stock, $0.0001 par value per share | +5.09K | $2.99 | +$15.2K | +8.8%62.6K after | |
| Sep 13, 2024 (view filing) | Sep 11 | 2 days | Wunsch Scott MCEO, Trinity Air Medical | SSaleClass A common stock, $0.0001 par value per share | −7.74K | $2.85 | −$22.1K | −2.6%285.0K after | |
| Sep 13, 2024 (view filing) | Sep 11 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −4.89K | $2.85 | −$13.9K | −6.2%74.6K after | |
| Nov 13, 2024 (view filing) | Nov 12 | 1 day | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −44.6K | $3.40 | −$151.7K | −3.7%1.17M after | 10b5-1 |
| Nov 15, 2024 (view filing) | Nov 14 | 1 day | Wiesenthal Robert SChief Executive Officer | SSaleClass A common stock, $0.0001 par value per share | −2.10M | $3.22 | −$6.76M | −30.4%4.81M after | |
| Nov 29, 2024 (view filing) | Nov 27-29 | 2 days | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −111.4K | $4.50 | −$501.6K | −9.5%1.06M after | 3 lots10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −23.8K | $5.02 | −$119.6K | −1.7%1.38M after | 10b5-1 |
| Dec 4, 2024 (view filing) | Dec 2-4 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −10.2K | $4.45 | −$45.2K | −13.6%64.4K after | 2 lots |
| Dec 11, 2024 (view filing) | Dec 9 | 2 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −39.3K | $5.02 | −$197.2K | −2.9%1.34M after | 10b5-1 |
| Dec 11, 2024 (view filing) | Dec 9 | 2 days | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −22.5K | $5.01 | −$112.7K | −2.1%1.04M after | 10b5-1 |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −5.09K | $4.05 | −$20.6K | −4.8%100.4K after | |
| Dec 17, 2024 (view filing)4:32 PM ET | Dec 13 | 4 days | Borthwick JohnDirector | SSaleClass A common stock, $0.0001 par value per share | −78.3K | $4.00 | −$313.3K | −31.7%168.4K after | |
| Jan 8, 2025 (view filing)4:38 PM ET | Jan 6-7 | 2 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −104.6K | $5.02 | −$525.0K | −7.9%1.22M after | 2 lots10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9 | 2 days | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −100.0K | $4.07 | −$407.0K | −6.8%1.36M after | 10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9 | 2 days | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −100.0K | $4.08 | −$408.0K | −8.0%1.15M after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Heyburn William A.Chief Financial Officer | SSaleClass A common stock, $0.0001 par value per share | −46.9K | $4.94 | −$231.8K | −3.4%1.34M after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Tomkiel Melissa M.President and General Counsel | SSaleClass A common stock, $0.0001 par value per share | −48.0K | $4.94 | −$237.1K | −4.0%1.15M after | 10b5-1 |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −11.0K | $4.31 | −$47.4K | −8.1%124.9K after | |
| Nov 24, 2025 (view filing) | Nov 20 | 4 days | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −11.0K | $4.37 | −$48.1K | −8.8%113.9K after | |
| Dec 5, 2025 (view filing) | Dec 5 | Same day | Lauck AndrewDirector | PPurchaseClass A common stock, $0.0001 par value per share | +5.00K | $4.37 | +$21.9K | +3.8%135.6K after | |
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Heyburn William A.Co-CEO and CFO | PPurchaseClass A common stock, $0.0001 par value per share | +17.0K | $4.47 | +$76.0K | +1.2%1.40M after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −14.3K | $5.79 | −$82.8K | −6.6%202.1K after | 10b5-1 |
| May 26, 2026 (view filing) | May 21-22 | 5 days | Cohen AmirChief Accounting Officer | SSaleClass A common stock, $0.0001 par value per share | −50.9K | $5.89 | −$299.4K | −25.2%151.3K after | 2 lots10b5-1 |
| Aug 13, 2026 (view filing)5:33 PM ET | Aug 10 | 3 daysLate | Love ReginaldDirector | SSaleClass A common stock, $0.0001 par value per share | −5.09K | $5.75 | −$29.3K | −3.4%146.5K after |